Blood-brain barrier impairment with enhanced SP, NK-1R, GFAP and Claudin-5 expressions in experimental cerebral toxocariasis

Pharmacology, Toxicology and Pharmaceutical Science

• Blood-Brain Barrier 100%
• Claudin 5 100%
• Neurokinin 1 Receptor 100%
• Toxocariasis 100%
• Glial Fibrillary Acidic Protein 100%
• Substance P 100%
• Infection 33%
• Canis 33%
• Mouse 22%
• Injury 22%
• Evans Blue 22%
• Western Blot 11%
• RNA Directed DNA Polymerase 11%
• Glycine Dehydrogenase (Decarboxylating) 11%
• Toxocara canis 11%
• Tight Junction Protein 11%
• Neuropeptide 11%

Biochemistry, Genetics and Molecular Biology

• Blood Brain Barrier 100%
• Substance P 100%
• Eicosanoid Receptor 100%
• Glial Fibrillary Acidic Protein 100%
• Claudin 100%
• Canis 33%
• Mouse 22%
• Messenger RNA 22%
• Evans Blue 22%
• Protein Expression 11%
• Vasodilatation 11%
• Reverse Transcription Polymerase Chain Reaction 11%
• Toxocara canis 11%
• Cell Infiltration 11%
• Leukocyte 11%
• Western Blot 11%
• Neuropeptide 11%

Immunology and Microbiology

• Blood Brain Barrier 100%
• Claudin 100%
• Canis 33%
• Mouse 22%
• Protein Expression 11%
• Western Blot 11%
• Toxocara canis 11%
• Leukocyte 11%
• Cell Infiltration 11%
• Inflammatory Cell 11%
• Reverse Transcription Polymerase Chain Reaction 11%
• Vasodilatation 11%
• Tight Junction 11%